Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
Clinical trial NCT02243202 · COMPLETED
Trial details
- NCT number
- NCT02243202
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2015-06-01
- Enrollment
- 335
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.